Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole.

Abstract

Single-agent use with itraconazole in heart or lung transplant recipients did not affect the rate of fungal infection as compared with previous reports. The incidence of fungal infection increased significantly within 3 months after escalation of immunosuppressant for treatment of acute rejection.